Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for Treatment of Atrial Fibrillation

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced U.S. Food and Drug Administration approval of its TactiCath™ Quartz irrigated ablation catheter, the company’s newest technology that . . . → Read More: Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for Treatment of Atrial Fibrillation Similar Articles: Market Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Reports Third Quarter 2014 Results Market Update (NYSE:STJ): St. Jude Medical Receives CE Mark Approval for Pacing Lead Labeling That Will Expand Patient Access to MRI Scans Company Update (NYSE:STJ): St. Jude Medical Announces Launch of OPTISTM Integrated System